All Stories

  1. Survival among children and adults treated with granulocyte transfusions: Twenty years’ experience at a Brazilian blood center
  2. Prevalence and Risk Factors for Human T-Cell Lymphotropic Virus (HTLV) in Blood Donors in Brazil—A 10-Year Study (2007–2016)
  3. The impact of immediate adverse donation reactions on the return of volunteers undergoing platelet apheresis
  4. Immunogenicity of personalized dendritic-cell therapy in HIV-1 infected individuals under suppressive antiretroviral treatment: interim analysis from a phase II clinical trial
  5. Knowledge of Hepatitis C virus vertical transmission and subsequent pregnancy outcome in virus-positive female blood donors
  6. Influence of unreported HIV prophylaxis on the kinetics of post‐blood donation HIV seroconversion
  7. Higher risk of death from COVID-19 in low-income and non-White populations of São Paulo, Brazil
  8. Occult and active hepatitis B virus detection in donated blood in São Paulo, Brazil
  9. HIV primary drug resistance and associated HIV risk factors among HIV positive blood donors in Brazil from 2007 to 2017
  10. Correlation between SARS‐COV‐2 antibody screening by immunoassay and neutralizing antibody testing
  11. Detection and analysis of blood donors seropositive for syphilis
  12. Three-quarters attack rate of SARS-CoV-2 in the Brazilian Amazon during a largely unmitigated epidemic
  13. Declining antibody levels to Trypanosoma cruzi correlate with polymerase chain reaction positivity and electrocardiographic changes in a retrospective cohort of untreated Brazilian blood donors
  14. Characterization of HIV risks in a Brazilian sickle cell disease population
  15. 10‐year analysis of human immunodeficiency virus incidence in first‐time and repeat donors in Brazil
  16. Association of HIV infection with clinical and laboratory characteristics of sickle cell disease
  17. Obesity and ABO blood group: Is there an association?
  18. Are different motivations and social capital score associated with return behaviour among Brazilian voluntary non‐remunerated blood donors?
  19. Validation of a formula predictive of peripheral blood stem cell yield and successful collection in healthy allogeneic donors
  20. Prevalence of serologic markers of transfusion and sexually transmitted infections and their correlation with clinical features in a large cohort of Brazilian patients with sickle cell disease
  21. Quality of life in pre-adolescent children with sickle cell disease in Brazil
  22. Test seeking: are healthcare professionals referring people to blood centers for infections marker testing?
  23. Social and behavioral characteristics of male blood donors and their sexual partners: an analysis to define risk subsets
  24. Does deferral for high‐risk behaviors improve the safety of the blood supply?
  25. Molecular characterization of viruses associated with encephalitis in São Paulo, Brazil
  26. Cytomegalovirus causes pulmonary embolism and can be treated with rivaroxaban
  27. Cascade of care and predictors of loss to follow-up among patients with hepatitis C.
  28. Text message, letter, or telephone call reminders to improve return of blood donors for counseling.
  29. Duration of Dengue Viremia in Blood Donors and Relationships Between Donor Viremia, Infection Incidence and Clinical Case Reports During a Large Epidemic
  30. Quality of life among blood donors with hepatitis B and hepatitis C
  31. Evolution of hepatitis C sutypes in São Paulo, Brazil
  32. Risk factors for anemia and iron deficiency among blood donation candidates
  33. Thrombosis and hereditary hemochromatosis mutations
  34. Risk factors among blood donors with positive syphilis markers
  35. Tools to improve hemovigilance
  36. Contribution of REDS to blood safety in Brazil
  37. Quality of live in chronic hepatitis C and B
  38. HCV genotypes, drug-resistence and risk factors for infection
  39. HIV knowledge and attitutes
  40. Prevalence of T. pallidum DNA among blood donors with positive tests for syphilis
  41. Response to: Chagas cardiomyopathy incidence
  42. Undisclosed HIV risk factors among blood donors
  43. HIV risk factors among blood donors in Brazil
  44. Chagas cardiomyopathy incidence
  45. Policies to mitigate TRALI in Brazil
  46. Temporal distribution of Brazilian blood donors
  47. Donors motivation and social capital
  48. Social capital and test seeking
  49. HBV and HCV markers among blood donors in Brazil
  50. Patterns of return among blood donors in Brazil
  51. Number of sexual partners and serologic markers among Brazilian blood donors
  52. Retention of blood donors
  53. CUE policies in Brazil
  54. Performance of dual immunoassay (IAs) screening in Brazil
  55. Impact of donors education on behavioral deferral
  56. 2-Red Blood Cell (2-RBC) and iron stores
  57. Comparison of two different methods of anemia screening in women
  58. Efficacy of donor arm disinfection
  59. Blood donors with syphilis in Sao Paulo, Brazil.
  60. Succesful outcome in poor-prognostic trombocitopenic trombotic purpura (TTP)
  61. HIV infection risk in Sao Paulo donors
  62. Deferral criteria on prevention of Creutzfeldt Jakob Disease and its variants
  63. Elevated ALT in blood donors
  64. Response to: anti-HBc isolated in blood donors
  65. p24 donor screening in Brazil
  66. Isolated anti-HBc in blood donors
  67. Serologic diagnosis of Chagas´Disease